# Molecular Signature From Tumor to Lymph Nodes

> **NCT04677205** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- Lung Cancer
- Stage IIIA-cN2
- Operated With Curative Intent
- Primary Tumor Tissue Available
- Node Tumor Tissue Available

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04677205
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-30
- **Primary completion:** 2023-11
- **Final completion:** 2027-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677205, "Molecular Signature From Tumor to Lymph Nodes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04677205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*